Nuevozen unveils breast cancer screening solution for healthcare providers that enables customized screening for patients

Nuevozen Screening App
Nuevozen Screening App
CHICAGO - Dec. 2, 2021 - PRLog -- Nuevozen, a California based healthcare technology company unveils breast cancer screening solution. Delayed screening and diagnosis of breast cancer reduces patients 5-year survival rate from 99% to 27%. By using Nuevozen screening application, healthcare providers will be able to provide a high quality of care and improve patient outcome.

"I am very excited to announce the unveiling of our industry leading screening solution," stated Karan Aujla, Nuevozen's Chief Executive Officer. "Our team has worked very diligently in developing the solution by closely collaborating with our pilot customers. The screening application has been already used by thousands of patients at our pilot customer. The solution has significantly improved productivity and quality of care at our pilot customer. I couldn't be prouder of unveiling of our screening solution."

Nuevozen's screening solution has two key components, a) customizable patient in-take App that works on the web or IPAD, and b) Risk assessment algorithm that provides a 10-year and lifetime risk (LTR) of developing breast cancer based on patients medical and family history. Risk profile is calculated using clinical risk models like Gail, Tyrer-Cuzick and machine learning.

The in-take app seamlessly integrates with Radiology Information System (RIS) workflow and can capture patient's medical and family history including genetics. Healthcare providers can customize the in-take questions and add their brand identity. Patients can input information at home or at the clinic. Based on the 10-year risk profile, physicians can decide on appropriate diagnosis and follow-ups.

The company is in the process of developing a comprehensive breast cancer diagnostic solution that leverages application of Artificial Intelligence on all available data like patient history, radiology images and demographics. Screening App is available as a cloud-based solution and healthcare providers can evaluate the solution for free by signing up at

About Nuevozen Corp.
Founded in 2019, Nuevozen Corp. is a privately held Healthcare technology company located in San Francisco Bay Area. Nuevozen' mission is to help healthcare providers in improving quality of care. For more information, contact or visit

Nuevozen Corp.
Karan Aujla

Email:*** Email Verified
Tags:Breast Cancer Screening, Radiology, Cancer Risk Assessment
Location:Chicago - Illinois - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse

Like PRLog?
Click to Share